Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Sales5886848841 0461 1621 281
Operating income (EBITDA)136161231284323363
Operating profit (EBIT)-120185239275311
Pre-Tax Profit (EBT)-105170230263296
Net income67,572,5139162186212
P/E ratio24,934,239,034,129,726,4
EPS ( € )0,820,791,511,772,042,30
Dividend per Share ( € )0,200,220,330,370,420,69
Yield0,98%0,81%0,56%0,62%0,70%1,14%
Reference price ( € )20.308326.883358.960.5160.5160.51
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Debt-87,486,474,7--
Finance----5,5391,2
Operating income (EBITDA)136161231284323363
Leverage
(Debt/EBITDA)
-0,54x0,37x0,26x--
Capital Expenditure29,347,153,074,077,980,0
Book Value Per Share (BVPS)-5,78 €6,96 €8,40 €10,2 €12,1 €
Cash Flow per Share-1,21 €1,52 €2,16 €2,46 €2,70 €
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 578 M€ -
Entreprise Value (EV) 5 653 M€ 5 572 M€
Valuation 2016e 2017e
P/E ratio (Price / EPS) 34,1x 29,7x
Capitalization / Revenue 5,33x 4,80x
EV / Revenue 5,40x 4,80x
EV / EBITDA 19,9x 17,2x
Yield (DPS / Price) 0,62% 0,70%
Price to book (Price / BVPS) 7,21x 5,95x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,9% 23,6%
operating Leverage (Delta EBIT / Delta Sales) 1,61x 1,34x
Net Margin (Net Profit / Revenue) 15,5% 16,0%
ROA (Net Profit / Asset) 12,6% 12,8%
ROE (Net Profit / Equities) 21,4% 20,5%
Rate of Dividend 21,0% 20,7%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   7,07% 6,70%
Cash Flow / Sales 19,0% 19,5%
Capital Intensity (Assets / Sales) 1,23x 1,25x
Financial Leverage (Net Debt / EBITDA) 0,26x -0,02x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend